KPS Corporation (256940) - Cash Flow Conversion Efficiency
Based on the latest financial reports, KPS Corporation (256940) has a cash flow conversion efficiency ratio of -0.036x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-3.20 Billion ≈ $-2.17 Million USD) by net assets (₩89.95 Billion ≈ $60.96 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 256940 market cap overview for the company's overall valuation and market capitalisation.
KPS Corporation - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how KPS Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data.
KPS Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of KPS Corporation ranked by their cash flow conversion efficiency. Explore 256940 cash flow quality score to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Falcon Metals Ltd
AU:FAL
|
-0.177x |
|
BIEN SPAREB.AS NK 34375
F:JX0
|
-0.180x |
|
Sterling Tools Limited
NSE:STERTOOLS
|
0.055x |
|
American Lithium Corp
V:LI
|
-0.019x |
|
Inovio Pharmaceuticals Inc
NASDAQ:INO
|
2.795x |
|
LBG MEDIA PLC LS -001
F:S83
|
0.059x |
|
West Vault Mining
V:WVM
|
-0.004x |
|
Interlink Communication Public Company Limited
BK:ILINK
|
0.051x |
Annual Cash Flow Conversion Efficiency for KPS Corporation (2016–2024)
The table below shows the annual cash flow conversion efficiency of KPS Corporation from 2016 to 2024. View KPS Corporation share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩63.22 Billion ≈ $42.84 Million |
₩4.81 Billion ≈ $3.26 Million |
0.076x | +7898.93% |
| 2023-12-31 | ₩58.58 Billion ≈ $39.70 Million |
₩-57.13 Million ≈ $-38.72K |
-0.001x | +94.03% |
| 2022-12-31 | ₩53.07 Billion ≈ $35.97 Million |
₩-866.26 Million ≈ $-587.05K |
-0.016x | +88.11% |
| 2021-12-31 | ₩61.03 Billion ≈ $41.36 Million |
₩-8.38 Billion ≈ $-5.68 Million |
-0.137x | -296.47% |
| 2020-12-31 | ₩50.16 Billion ≈ $33.99 Million |
₩-1.74 Billion ≈ $-1.18 Million |
-0.035x | -43.50% |
| 2019-12-31 | ₩30.30 Billion ≈ $20.53 Million |
₩-731.24 Million ≈ $-495.55K |
-0.024x | -131.44% |
| 2018-12-31 | ₩30.91 Billion ≈ $20.95 Million |
₩2.37 Billion ≈ $1.61 Million |
0.077x | -69.49% |
| 2017-12-31 | ₩25.75 Billion ≈ $17.45 Million |
₩6.48 Billion ≈ $4.39 Million |
0.252x | -0.58% |
| 2016-12-31 | ₩6.25 Billion ≈ $4.24 Million |
₩1.58 Billion ≈ $1.07 Million |
0.253x | -- |
About KPS Corporation
Keeps Biopharma Inc. engages in the research, development, production, and sale of mechanical equipment for manufacturing flat panel displays in South Korea, China, and internationally. It offers OLED equipment, inspection technologies, camera modules, precision systems, and TSP/solar products. The company is also involved in bio research and development business; waste battery recycling; and oth… Read more